Thursday, October 12, 2017

FDA advisers review gene therapy to treat form of blindness

  1. FDA advisers review gene therapy to treat form of blindness  Washington Post
  2. FDA Vote Sets Stage for Gene Therapy's Future  MIT Technology Review
  3. Live updates: FDA advisory panel reviews Spark's gene therapy  STAT
  4. Gene therapy drug developed in Philadelphia helps people with rare hereditary blindness see  Philly.comFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Headlines